期刊文献+

PTEN基因ⅣS4多态性与脂代谢紊乱的关系 被引量:1

Association of PTEN ⅣS4 polymorphisms with lipid metabolism disorder
下载PDF
导出
摘要 目的:探讨PTEN基因ⅣS4(rs3830675)多态性与川南地区汉人脂代谢紊乱的关系。方法:应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析结合DNA测序方法,对431例样本进行PTEN基因ⅣS4多态性分析,其中脂代谢紊乱患者208例(脂代谢紊乱组),对照样本223例(对照组)。结果:PTEN基因ⅣS4基因型(-/-、-/+、+/+)在对照组和脂代谢紊乱组中分布具有统计学差异(P=0.039)。ⅣS4基因型+/+相对于基因型-/-和-/+以及等位基因+相对于等位基因-发病风险增加,OR值分别为1.768(95%CI:1.135~2.753,P=0.011)和1.480(95%CI:1.135~1.929,P=0.004)。另外,与基因型-/-和-/+比较,基因型+/+的平均总胆固醇(TC)水平显著增加(t=-2.349,P=0.020),平均低密度脂蛋白胆固醇(LDL-C)水平也显著增高(t=-2.767,P=0.006),其他检测指标无统计学差异。结论:PTEN基因ⅣS4+/+基因型和等位基因+是川南地区脂代谢紊乱的危险因素,其主要的关系可能与TC和LDL-C相关。 Objective To investigate the association of PTEN gene Ⅳ S4 polymorphisms with lipid metabolism disorder in the Han people who lives in southern Sichuan areas. Methods PTEN gene Ⅳ S4 polymorphisms were detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing in 431 samples (208 from patients with dyslipidemia and 223 from control subjects ). Results The frequencies of ⅣS4 genotypes (- /-, - /+, and+/ + ) differed statistically between the control subjects and patients with lipid metabolism disorder (P=0.039). As compared with ⅣS4 genotypes-/ - and-/+and allele (+), genotype+/ + and allele (-) had an increased risk of lipid metabolism disorder [OR: 1.768, 95% CI: 1.135~2.753, P=0.011] and [OR: 1.480, 95%CI: 1.135~1.929, P=0.004). In addition, levels of TC and LDL-C were markedly higher in ⅣS4 genotype+/ + than genotypes-/ - and-/+(t =-2.349, P=0.020 and t=- 2.767, P=0.006). Conclusions PTEN ⅣS4 genotype+/ + and allele (+) are the risk factor of lipid metabolism disorder in southern Sichuan areas, which is mainly associated with TC and LDL-C.
出处 《实用医学杂志》 CAS 北大核心 2013年第13期2113-2116,共4页 The Journal of Practical Medicine
基金 四川省卫生厅科研课题(编号:120348)
关键词 多态性 单核苷酸 PTEN基因ⅣS4多态性 脂代谢紊乱 Polymorphism, single nucleotide PTEN gene ⅣS4 polymorphisms Lipid abnormalities
  • 相关文献

参考文献13

  • 1Yang W, Xiao J, Yang Z, et al. Serum lipids and lipoproteins in Chinese men and women EJ. Circulation, 2012, 125 (18) : 2212-2221.
  • 2韩莹,郭志刚,袁勇.中山市社区人群血脂水平、生活方式干预及2年随访研究[J].实用医学杂志,2009,25(8):1321-1323. 被引量:3
  • 3严励,王川.糖尿病血脂异常研究新进展[J].中华内分泌代谢杂志,2012,28(9):704-709. 被引量:18
  • 4Subramanian K K, Jia Y, Zhu D, et al. Tumor suppressor PTEN is a physiologic suppressor of chemoattractant mediated neutrophil functions [J]. Blood, 2007, 109(9) :4028-4037.
  • 5Tsoyi K, Jang H J, Nizamutdinova I T, et al. PTEN differentially regulates expressions of ICAM-1 and VCAM-I through PI3K/Akt/GSK-3beta/GATA-6 signaling pathways in TNF-alpha activated human endothelial cells [ J ]. Atherosclerosis. 2010. 213(1)_. 115-121.
  • 6Stiles B, Wang Y, Stahl A, et al. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [J]. Proc Natl Acad Sci, 2004, 101(7): 2082-2087.
  • 7Alisi A, Bruscalupi G, Pstore A, et al. Redox homeostasis and posttranslational modifications/activity of phosphatase and tensin homolog in hepatocytes from rats with diet-induced hepatosteatosis [J]. J Nutr Biochem, 2012, 23(2) : 169-178.
  • 8Watanabe S, Horie Y, Kataoka E, et al. Non-alcoholic steatohepatitis and hepatoeellular carcinoma: lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN)- deficient mice [J]. J Gastroenterol Hepatol, 2007, 22 (Suppl 1) : S96-S100.
  • 9Xu Z, Stokoe D, Kane L P, et al. The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells [J]. Cell Growth Differ, 2002, 13(7):285-296.
  • 10Hagenbeek T J, NasPetti M, Malergue F, et al. The loss of PTEN allows TCR lineage thymocytes to bypass IL-17 and Pre- TCR-mediated signaling [J]. J Exp Med, 2004, 200(7):883- 894.

二级参考文献54

  • 1李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1783
  • 2瞿龙,李风云,林蔚,王海燕,励海梅,朱秀琼,刘俊芳.社区中老年居民血脂异常、治疗和控制现状[J].现代预防医学,2007,34(11):2082-2084. 被引量:2
  • 3National cholesterol education program executive. Summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ) [J]. JAMA, 2001, 285(13) : 2486-2497.
  • 4The coordinating committee of the national cholesterol education program. Implications of recent clinical trials for the national cholesterol education program adult treatment panel Ⅲ guidelines [J]. Circulation, 2004, 110(2) : 227-239.
  • 5Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trim [J]. Lancet, 2002, 360(2): 23-33.
  • 6Blanco-Colio, Luis Miguel, Osende, et al. The ALLHAT-LLT and ASCOT-LLA trials: are the discrepancies more apparent than real [J]. Curr Atheroscler Rep, 2004, 6(1): 9-11.
  • 7Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer]. Science, 1997,275(5308) : 1943-1947.
  • 8Salmena L, Carracedo A, Pandolfi PP, et al. Tenets of PTEN tumor suppression[J]. Cell, 2008,133(3) : 403-414.
  • 9Heikkinen T,Greco D, Pelttari LM, et al. Variants on the pro- moter region oPTEN a{{ect breast cancer progression and pa- tient survival[J]. Breast Cancer Res, 2011,13 (6) : R130.
  • 10Carroll BT, Couch FJ, Rebbeck TR, et al. Polymorphisms in PTEN in breast cancer families[-J]. J Med Genet, 1999,36 (2) .. 94-96.

共引文献20

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部